share_log

Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23

Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23

Stephens & Co.Anika Therapeutics保持同等权重,将目标股价下调至23美元
Benzinga ·  2023/08/10 10:16

Stephens & Co. analyst George Sellers maintains Anika Therapeutics (NASDAQ:ANIK) with a Equal-Weight and lowers the price target from $28 to $23.

Stephens&Co.分析师George Sellers坚持Anika Treateutics(纳斯达克:ANIK)的同等权重,并将目标价从28美元下调至23美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发